首页> 外文期刊>Clinical and experimental ophthalmology >Revisiting transconjunctival sutureless 25-gauge vitrectomy: still worthwhile?
【24h】

Revisiting transconjunctival sutureless 25-gauge vitrectomy: still worthwhile?

机译:回顾结膜无缝25规格玻璃体切除术:仍然值得吗?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To present the outcomes of various retinal conditions treated with the sutureless 25-gauge (25G) vitrectomy technique. Retrospective case review of 232 eyes of 228 patients who underwent 25G vitrectomy from January 2003 to August 2006. Follow-up was a minimum of 3 months. Indications for surgery included idiopathic macular hole, rhegmatogenous retinal detachment, epiretinal membrane and proliferative diabetic retinopathy. Main outcome measures included final visual acuity, re-operation rate and surgical complications such as endophthalmitis, hypotony and retinal (re)detachment. For all cases, the mean overall visual acuity (logMAR) improved from 0.9 preoperatively to 0.5 (P < 0.0001). The improvement in acuity was highest in the rhegmatogenous detachment and diabetic groups. Transient postoperative hypotony was observed in 15 cases (9.2%) on day 1 after surgery but all these cases resolved. In 7.3% of the cases (17 out of 232) additional surgery was performed due to retina (re)detachment but final anatomic success was achieved in all cases; the detachments occurred within the first 3 months. One patients developed endophthalmitis (0.4%) which coincided with subconjunctival antibiotics being discontinued in favour of topical treatment. The 25G system remains a safe and effective technique for a variety of retinal conditions; significant fast visual rehabilitation is an advantage.
机译:展示采用无缝线25规格(25G)玻璃体切除术治疗的各种视网膜疾病的结果。从2003年1月至2006年8月,对228例接受25G玻璃体切除术的患者的232眼进行回顾性病例回顾。随访至少3个月。手术适应症包括特发性黄斑裂孔,视网膜源性视网膜脱离,视网膜前膜和增生性糖尿病性视网膜病变。主要结局指标包括最终视力,再次手术率和外科手术并发症,例如眼内炎,肌张力低下和视网膜(再)脱离。对于所有病例,术前平均总视敏度(logMAR)从术前的0.9提高到0.5(P <0.0001)。在流源性脱离和糖尿病组中,视力的改善最高。术后第1天观察到短暂性术后肌张力低下15例(9.2%),但所有这些病例均已解决。在7.3%的病例(232例中有17例)中,由于视网膜(再)脱离而进行了额外的手术,但所有病例均获得了最终的解剖学成功;支队发生在最初的3个月内。 1例患者发生眼内炎(0.4%),同时结膜下抗生素被停用,有利于局部治疗。 25G系统对于各种视网膜疾病仍然是一种安全有效的技术。快速的视觉康复是一大优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号